Exelixis, Inc. (Nasdaq:EXEL) announced that it granted restricted stock units representing 3,250 shares of Exelixis common stock to one new employee, Joerg Bussenius, Associate Director, Medicinal Chemistry. The restricted stock unit award vests as to 1/4th of the shares subject to the restricted stock unit award on the first established quarterly vesting date following the one-year anniversary of the employee’s date of hire and thereafter as to 1/16th of the original number of shares subject to the restricted stock unit award on each succeeding August 15th, November 15th, February 15th and May 15th subject to the new employee’s continued service relationship with Exelixis on each such date.
